Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Revenue (2010 - 2026)

Updated

Vistagen Therapeutics' Revenue was $138,000 in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 46.5% from $258,000 a year earlier and down 90.7% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Revenue (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vistagen Therapeutics' Revenue was $2.38 million through Sep 30, 2026, up 230.4% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $1.27 million, up 161.1% from FY2025.

  • Revenue shows a five-year compound annual growth rate of 3.1% (FY2021 to FY2026).
  • In earlier fiscal years, Revenue was $486,000 in FY2025 (-54.3%), $1.06 million in FY2024 (+368.7%), $227,000 in FY2023 (-79.5%) and $1.11 million in FY2022 (+1.8%).
  • The fiscal Q2 2027 figure marks the lowest quarterly Revenue since fiscal Q4 2025.
  • Compared with a year earlier, Revenue was higher in four of the last six quarters, with growth averaging 112.7%.
  • The best year-over-year quarter for Revenue over five years was fiscal Q1 2027 (growth of 504.9%); the worst was fiscal Q4 2022 (a decline of 91.2%).
  • Per Business Quant data, VTGN's Revenue in the three fiscal quarters before Q2 2027 was $1.48 million (Q1 2027), $465,000 (Q4 2026) and $303,000 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 212,806.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 24.40 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 25.40 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 17.40 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 18.09 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 8.30 Bn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - 138,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 138,000.00
Jun 30, 2026 1.48 Mn
Mar 31, 2026 465,000.00
Dec 31, 2025 303,000.00
Sep 30, 2025 258,000.00
Jun 30, 2025 244,000.00
Mar 31, 2025 -15,000.00
Dec 31, 2024 234,000.00
Sep 30, 2024 183,000.00
Jun 30, 2024 84,000.00
Mar 31, 2024 164,000.00
Dec 31, 2023 411,000.00
Sep 30, 2023 300,000.00
Jun 30, 2023 200,000.00
Mar 31, 2023 176,000.00
Dec 31, 2022 180,000.00
Sep 30, 2022 893,000.00
Jun 30, 2022 310,100.00
Mar 31, 2022 39,000.00
Dec 31, 2021 358,000.00
API Access

Vistagen Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=VTGN&period=max&api_key=YOUR_API_KEY